Blood pressure (BP) shows a continuous relationship with the risk of CVD. There is substantial evidence that dietary potassium exerts an antipressor effect. Most clinical trials have used KCl. However, the chloride ion may have a pressor effect and in foods potassium is associated with organic anions. In a double-blind randomized placebo-controlled trial we explored the effect on BP of two salts of potassium, KCl and potassium citrate (K-cit), in predominantly young healthy normotensive volunteers. The primary outcome was the change in mean arterial pressure as measured in a clinic setting. After 6 weeks of supplementation, compared with the placebo group (n 31), 30 mmol K-cit/d (n 28) changed mean arterial pressure by 25·22 mmHg (95 % CI 2 8·85, 24·53) which did not differ significantly from that induced by KCl (n 26), 2 4·70 mmHg (2 6·56, 22·84). The changes in systolic and diastolic BP were 26·69 (95 % CI 2 8·85, 24·43) and 2 4·26 (95 % CI 26·31, 2 2·21) mmHg with K-cit and 25·24 (95 % CI 2 7·43, 23·06) and 24·30 (95 % CI 26·39, 22·20) mmHg with KCl, and did not differ significantly between the two treatments. Changes in BP were not related to baseline urinary electrolytes. A greater treatment-related effect was observed in those with higher systolic BP. Increasing dietary potassium could therefore have a significant impact on the progressive rise in BP in the entire population.